Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients

Practical Nomogram Predicting Apixaban or Rivaroxaban Concentrations from Low-Molecular-Weight Heparin Anti-Xa Values: Special Interest in Acute Ischemic Stroke Patients

Background and Purpose In patients with acute ischemic stroke (AIS) using a direct oral factor-Xa anticoagulant (DOAC) during the last 48 hours, a fixed plasma heparin-calibrated anti-Xa activity (0.5 IU/mL) was proposed as a threshold below which patients could be eligible for thrombolysis and/or t...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Charlyne Brakta, Alain Stépanian, Peggy Reiner, Maxime Delrue, Mikaël Mazighi, Emmanuel Curis, Virginie Siguret
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Korean Stroke Society 2023-01-01
Saila:Journal of Stroke
Gaiak:
fibrinolysis
stroke
anticoagulant
doac
anti-xa
low-molecular-weight heparin
nomogram
Sarrera elektronikoa:http://www.j-stroke.org/upload/pdf/jos-2022-03034.pdf

Internet

http://www.j-stroke.org/upload/pdf/jos-2022-03034.pdf

Antzeko izenburuak